Introduction: Excess body weight (body mass index [BMI] ≥ 25.00 kg/m 2 ) is an established risk factor for diabetes, hypertension and cardiovascular disease, but its relationship to cancer is lesser-known. This study used population attributable fractions (PAFs) to estimate the cancer burden attributable to excess body weight in Canadian adults (aged 25+ years) in 2010.
• An estimated 9645 cancer cases or 5.7% of all cancers diagnosed in Canadian adults (aged 25+ years) were attributable to excess body weight in 2010. • Cancers with the greatest proportion of cases attributable to excess body weight included esophageal adenocarcinoma, kidney, gastric cardia, liver, colon and gallbladder for males, and esophageal adenocarcinoma, uterus, gallbladder and kidney for females. • Cancers contributing the greatest number of cases attributable to excess body weight were colon, kidney and advanced prostate for males, and uterus, postmenopausal breast and colon for females. • The proportion of cancers attributable to excess body weight was highest in the Prairies (except Alberta) and the Atlantic region, and lowest in British Columbia and Quebec.
Although excess body weight is an established risk factor for diabetes, hypertension and cardiovascular disease, its relationship to cancer is lesser-known. 6 In 2002, the International Agency for Research on Cancer concluded that excess body weight is associated with an increased risk of developing cancers of the colon, breast (postmenopausal), endometrium, kidney and esophagus (adenocarcinoma), 6 and more recent systematic reviews have identified additional cancers. [7] [8] [9] [10] Cited potential carcinogenic mechanisms include hormonal and metabolic changes, elevated oxidative stress, stimulation of the body's inflammatory response and increased gastroesophageal reflux https://doi.org/10.24095/hpcdp.37.7.01
Introduction
The burden of cancer on the Canadian population is heavy. Currently, the lifetime risk of developing cancer is 45% for males and 42% for females, 1 and cancer is the leading cause of death in Canada, accounting for 30% of all deaths in 2012. 2 Consequently, understanding the main drivers of the cancer burden is a public health priority. Population attributable fractions (PAFs) can be used to quantify the impact of different factors on the occurrence of cancer in a population and thus are of value in prioritizing cancer control strategies. Assuming a causal relationship between a specific factor and cancer, the PAF estimates the proportion of cancer cases that could be prevented by eliminating the specific factor from the population. 3, 4 In a recent British study using PAFs to estimate the proportion of cancers attributable to lifestyle and environmental risk factors, tobacco use, diet and excess body weight were identified as the top three risk factors, accounting for 19.4%, 9.2% and 5.5% of all cancers, respectively. 5 caused by the direct mechanical effects of central obesity. 6, 7, 11 Several relatively recent studies have examined the proportion of cancers attributable to excess body weight in Canada 12, 13 and also specifically in Ontario. 14 However, additional types of cancer have since been identified as having strong evidence of a causal relationship with excess body weight. As well, none of the previous research provided a comprehensive regional examination of PAFs in Canada. Considering the growing recognition of body weight as a risk factor for cancer and the rising prevalence of excess body weight in the Canadian population, 15 more current, comprehensive estimates of the proportion of cancers attributable to excess body weight are needed to guide cancer control strategies. The primary objective of this study is to estimate the proportion and number of new cancer cases attributable to excess body weight in Canadian adults, aged 25 years and older, in 2010.
Methods

Prevalence of excess body weight in the Canadian population
We used body mass index (BMI), a commonly used measure with established cut points for excess body weight 16 (defined as a BMI of 25.00+ kg/m 2 ; Table 1 ), to quantify the prevalence of overweight and obese Canadians. We used self-reported height and weight, obtained from the Canadian Community Health Survey (CCHS), 17 to calculate BMI (weight in kilograms divided by squared height in metres). The CCHS, a population-based survey initiated in 2000, was designed to provide reliable estimates at the health region and provincial levels for the population aged 12 years and older, with some exclusions representing less than 3% of the Canadian population. Canadian research has demonstrated that BMI based on self-report is biased downward because people overreport their height and underreport their weight. 18 Therefore, we adjusted BMIs for this study using correction formulas previously developed on a subsample of CCHS respondents who agreed to have their height and weight measured in addition to providing self-reports (Equations 1 and 2). 19, 20 To estimate the proportion of cancer cases in 2010 attributable to excess body weight, the prevalence of excess body weight in 2000 and 2001 was used to allow at least a 10-year latency period between exposure (excess body weight) and disease (cancer). For example, the proportion of cancers attributed to excess body weight among adults aged 45 to 54 years in 2010 was based on the prevalence of overweight and obese adults aged 35 to 44 years in 2000 and 2001. A 10-year latency was the longest possible period available using the CCHS, and is consistent with similar research 12, 21, 22 as well as the range of geometric mean duration of follow-up in a comprehensive meta-analysis examining the association between body weight and several types of cancer. 8 To acknowledge the sampling design of the CCHS, we weighted all estimates and obtained corresponding variance estimates using balanced repeated replication with the provided replicate weights. The national response rate for the CCHS in 2000 and 2001 was 84.7%. 17
Associations between excess body weight and cancer
Cancers with strong evidence of a causal relationship with high BMI were identified through the World Cancer Research Fund (WCRF) International Continuous Update Project (CUP), an ongoing program analyzing global research on how diet, nutrition, physical activity and weight affect cancer risk and survival. 23 The CUP completes thorough systematic reviews and meta-analyses primarily of randomized controlled trials, cohort and nested casecontrol studies. Estimates of association that are most adjusted for confounding and have adequate data for dose-response are used in the meta-analyses. These reviews are evaluated by an independent expert panel who draw conclusions regarding the strength of evidence supporting the relationships. Strong evidence is considered strong enough to generally justify recommendations designed to reduce the incidence of cancer. At a minimum, strong evidence includes the following: proof from at least two independent cohort studies or at least five case-control studies; no substantial unexplained heterogeneity; good-quality studies that exclude the possibility of random or systematic error; and biological plausibility. Additional criteria include evidence from more than one study type; the presence of a dose-response association; and strong and plausible human or animal experimental evidence that typical human exposures can lead to cancer. 24 According to the WCRF International CUP, there is strong evidence supporting a causal relationship between high BMI and 12 cancers ( Table 2 ). The sex-specific relative risk (RR) estimates extracted for this study were those based on cohort studies examining incident cancer as the outcome. We converted RR estimates associated with a five-unit increase in BMI to RR estimates for a one-unit increase in BMI by assuming a linear relationship between the natural logarithm of the RR and BMI. For males, the relative risk (RR) of cancer associated with a one-unit increase in BMI ranged from a low of 1.02 for pancreatic, rectal and advanced prostate cancer to a high of 1.09 for esophageal adenocarcinoma. For females, the increased risk ranged from 1.01 for rectal and ovarian cancer to 1.08 for esophageal adenocarcinoma and uterine cancer.
Number of new cancer cases in Canada in 2010
We Cancer definitions were aligned with the meta-analysis quantifying their association with BMI (Table 3 ). Because staging information was not complete for all prostate cancers, particularly in certain provinces, we obtained estimates of the proportion of stage III and stage IV prostate cancers by age group using all staged prostate cancers diagnosed in Canada (excluding Quebec) during 2010.
Case counts for Quebec needed to be adjusted for a few cancers not directly available through Statistics Canada's website. Specifically, we estimated the number of esophageal adenocarcinomas and cancers of the gastric cardia and liver (including intrahepatic bile duct) for Quebec using information available for all provinces and territories except Quebec. For example, the proportion of esophageal cancers that were adenocarcinomas in Quebec were estimated using sex-and age-specific proportions for all of Canada, except Quebec, in 2010. For confidentiality reasons, presented case counts were randomly rounded to an adjacent multiple of 5 using an unbiased random rounding scheme; actual case counts ending in 0 or 5 were not rounded.
Population attributable fractions (PAFs)
We estimated PAFs specific to cancer, region, sex and age group as per Equation 3. 4
The RR associated with a BMI category was quantified relative to 21 kg/m 2 , an accepted optimal value, 40 using Equation 4. We assumed no risk for BMI less than 25.00 kg/m 2 .
The product of the PAF specific to cancer, region, sex and age group and corresponding incident cancers provided the number of cancer cases attributable to excess body weight. Thereafter, summations across relevant strata (e.g. type of cancer, region, sex and age) provided PAFs and Notes: Topography and histology are classified according to the International Classification of Diseases for Oncology. 37 Cancer definitions were aligned with the meta-analysis quantifying their association with BMI (see Table 2 ). When further clarification was needed, the Surveillance, Epidemiology and End Results Program Site Recode 38 Table 2 .
Results
Prevalence of excess body weight
A detailed examination of the prevalence of excess body weight was not the primary objective of this study. Rather, we estimated prevalence of excess body weight by region, sex and age group in order to estimate PAFs. Nonetheless, a few observations warrant mention because the prevalence of excess body weight is one of the main drivers of PAFs. First, across the country in 2000 and 2001, males were more likely than females to be overweight, but the proportion classified as obese was similar across the sexes (Figure 1 ). Second, the proportion of adults classified as overweight varied less across the country than the proportion of adults classified as obese. Specifically, British Columbia and Quebec had the lowest prevalence of obese adults, while Saskatchewan, Manitoba, the Atlantic region and the territories had the highest prevalence.
Cancers attributable to excess body weight
PAFs, attributable cases and plausible ranges are shown by type of cancer, sex and region in Notes: BMI was calculated using self-reported weight and height from the Canadian Community Health Survey. 17 BMI was corrected for self-report bias prior to being categorized according to WHO guidelines. 16 Overweight is defined as 25.00 kg/m 2 ≤ BMI ≤ 29.99 kg/m 2 . Obese is defined as BMI ≥ 30.00 kg/m 2 . Error bars represent 95% confidence intervals. Plausible range estimated using the 95% confidence limits of the relative risks in Table 2 .
TABLE 4 Population attributable fractions and attributable cancer cases for excess body weight a in Canadian adults (aged 25+) in 2010, by sex and region
c Because relative risks were estimated to two decimal places, the lower end will be zero for male liver cancer and female rectal and ovarian cancer, and the point estimate will be the same as the lower or upper end for male rectal and advanced prostate cancer and postmenopausal breast cancer. 
Strengths and limitations
This study has several strengths compared to previously published Canadian research. First, our study included PAFs for additional cancers with strong evidence of a causal relationship with excess body weight. Second, the RR assigned to the overweight and obese categories acknowledged the BMI distribution within the categories relative to an optimal BMI (21 kg/m 2 ). Third, we provided PAFs and counts of cancer cases attributable to excess body weight for regions within Canada in addition to the whole country. Fourth, we corrected BMI for self-report bias using formulas developed and validated with CCHS respondents. Using corrected BMIs increased the overall PAF by about 20% from 4.8% (males 4.2%, females 5.4%) to 5.7% (males 4.9%, females 6.5%).
Some limitations, however, should be acknowledged when interpreting the results of this study.
First, BMI does not distinguish between weight associated with muscle or fat; thus, the relationship between BMI and body fat varies with body build, sex, age and ethnicity. 16 Second, BMI measurements at a specific point in time do not acknowledge potential cancer-specific, time-dependent effects of high BMI on cancer risk. Some research indicates that the risk of cancer from high BMI increases with the number of years lived with a high BMI, and that young adult BMI may be more strongly associated with cancer risk than BMI later in life. [41] [42] [43] Third, the association between BMI and cancer may differ across populations. 44 The measures of association used in this study were not specific to Canada. Nevertheless, Renehan et al. 8 found that, for many cancers, the increased risk associated with increasing BMI were consistent across populations. A notable exception was breast cancer: increasing BMI increased the risk of pre-menopausal breast cancer in Asia-Pacific regions but decreased the risk in other regions; and the postmenopausal breast cancer risk associated with increasing BMI was greater in Asia-Pacific regions than other regions. The RR estimate used for postmenopausal breast cancer in this study, however, was consistent with that for North America.
Fourth, RRs used in Equation 3 should not be adjusted for confounding. 4 However, appropriate use of Equation 3 with adjusted RRs would require availability of exposure and disease data stratified by confounding variable(s), a situation generally not available. Interestingly, Renehan et al. 8 reported that repetition of analyses with minimally adjusted RRs rather than maximally adjusted RRs did not produce different results with respect to the association between BMI and cancer. Further, calculating PAFs within age-and sex-specific strata, two variables commonly used to adjust RRs, may mitigate the impact of using adjusted RRs in this study. 44 Fifth, additional types of cancer (meningioma, thyroid and multiple myeloma), not included in this study, have recently been identified as having sufficient evidence of an association with excess body weight. Consequently, the PAFs and attributable cases reported in this study are probably underestimates of the true cancer burden of excess body weight in the Canadian adult population. 10 Sixth, although the CCHS participation rate was high (84.7%), samples are vulnerable to nonresponse bias. PAFs and attributable cases reported in this study will be biased downward if nonparticipants were more likely to be overweight or obese than participants and vice versa.
Seventh, it should be noted that PAFs are not exact, error-free estimates. Rather, uncertainty exists due to variation in the RRs used and in the prevalence of overweight and obesity estimates, and the statistical uncertainty inherent in estimation.
To acknowledge this uncertainty, plausible ranges were estimated for PAFs and attributable cancer cases using the 95% confidence limits of the RRs in Table 2 .
Conclusion
An estimated 5.7% (1 in 18) of all new cancer cases diagnosed in Canadian adults in 2010 were attributable to high BMI after correcting for bias in self-reported height
